Recent Finacing
Recent Raise
PurMinds develops psychedelic and non-psychedelic neurological therapeutics, holds a Canadian controlled-substances licence, collaborates to optimize BTLS delivery, and uses cGMP manufacturing plus compound library to advance leads to trials.